- Home
- NXL vs EMKR Comparison
NXL vs EMKR Comparison
Compare NXL & EMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- EMKR
- Stock Information
- Founded
- NXL 2010
- EMKR 1984
- Country
- NXL United States
- EMKR United States
- Employees
- NXL N/A
- EMKR N/A
- Industry
- NXL Medical Specialities
- EMKR Semiconductors
- Sector
- NXL Health Care
- EMKR Technology
- Exchange
- NXL Nasdaq
- EMKR Nasdaq
- Market Cap
- NXL 10.0M
- EMKR 9.5M
- IPO Year
- NXL 2022
- EMKR 1997
- Fundamental
- Price
- NXL $3.92
- EMKR $2.94
- Analyst Decision
- NXL Strong Buy
- EMKR Buy
- Analyst Count
- NXL 1
- EMKR 2
- Target Price
- NXL $3.00
- EMKR $3.00
- AVG Volume (30 Days)
- NXL 4.3M
- EMKR 508.4K
- Earning Date
- NXL 11-08-2024
- EMKR 12-10-2024
- Dividend Yield
- NXL N/A
- EMKR N/A
- EPS Growth
- NXL N/A
- EMKR N/A
- EPS
- NXL N/A
- EMKR N/A
- Revenue
- NXL $162,078.00
- EMKR $90,961,000.00
- Revenue This Year
- NXL $51.39
- EMKR N/A
- Revenue Next Year
- NXL $177.11
- EMKR $7.07
- P/E Ratio
- NXL N/A
- EMKR N/A
- Revenue Growth
- NXL 26.00
- EMKR 413.79
- 52 Week Low
- NXL $0.25
- EMKR $0.78
- 52 Week High
- NXL $4.36
- EMKR $7.20
- Technical
- Relative Strength Index (RSI)
- NXL 68.88
- EMKR 73.62
- Support Level
- NXL $2.40
- EMKR $2.90
- Resistance Level
- NXL $4.36
- EMKR $3.06
- Average True Range (ATR)
- NXL 0.63
- EMKR 0.10
- MACD
- NXL 0.08
- EMKR 0.06
- Stochastic Oscillator
- NXL 79.19
- EMKR 90.00
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About EMKR EMCORE Corporation
EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.